Tumor receptor imaging: Proceedings of the National Cancer Institute Workshop, review of current work, and prospective for further investigations

J. A. Katzenellenbogen, R. E. Coleman, R. A. Hawkins, Kenneth Krohn, S. M. Larson, J. Mendelsohn, C. K. Owborne, D. Piwnica-Worms, R. C. Reba, B. A. Siegel, M. J. Welch, F. Shtern

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

In February 1994, the National Cancer Institute held a workshop to evaluate the current and future role of emission tomographic imaging methods, positron emission tomography and single-photon emission computed tomography, in improving the accuracy of cancer diagnosis and the effectiveness of treatment and in elucidating basic aspects of human cancer biology. Reviews covered many of the receptor and transport systems for hormones and growth factors, as well as metabolic changes important in human cancer, and topical presentations reviewed the current status of receptor-based imaging in the most well-characterized systems: somatostatin receptor imaging of neuroendocrine tumors, estrogen receptor imaging of breast cancer, and epidermal growth factor receptor and tumor metabolic imaging. A critical analysis was made of the current research and of new directions for the future development and use of receptor-imaging methods in oncology. In each area, recommendations were made for further investigation, where emerging understanding of tumor cell biology and defined molecular targets might be combined with the methods of radiopharmaceutical design and evaluation, to develop new approaches to critical issues in the diagnosis, staging, and treatment of cancer through tumor receptor imaging.

Original languageEnglish (US)
Pages (from-to)921-932
Number of pages12
JournalClinical Cancer Research
Volume1
Issue number8
StatePublished - 1995
Externally publishedYes

Fingerprint

National Cancer Institute (U.S.)
Education
Neoplasms
Somatostatin Receptors
Neuroendocrine Tumors
Radiopharmaceuticals
Neoplasm Staging
Single-Photon Emission-Computed Tomography
Epidermal Growth Factor Receptor
Estrogen Receptors
Positron-Emission Tomography
Cell Biology
Intercellular Signaling Peptides and Proteins
Hormones
Breast Neoplasms
Research

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Katzenellenbogen, J. A., Coleman, R. E., Hawkins, R. A., Krohn, K., Larson, S. M., Mendelsohn, J., ... Shtern, F. (1995). Tumor receptor imaging: Proceedings of the National Cancer Institute Workshop, review of current work, and prospective for further investigations. Clinical Cancer Research, 1(8), 921-932.

Tumor receptor imaging : Proceedings of the National Cancer Institute Workshop, review of current work, and prospective for further investigations. / Katzenellenbogen, J. A.; Coleman, R. E.; Hawkins, R. A.; Krohn, Kenneth; Larson, S. M.; Mendelsohn, J.; Owborne, C. K.; Piwnica-Worms, D.; Reba, R. C.; Siegel, B. A.; Welch, M. J.; Shtern, F.

In: Clinical Cancer Research, Vol. 1, No. 8, 1995, p. 921-932.

Research output: Contribution to journalArticle

Katzenellenbogen, JA, Coleman, RE, Hawkins, RA, Krohn, K, Larson, SM, Mendelsohn, J, Owborne, CK, Piwnica-Worms, D, Reba, RC, Siegel, BA, Welch, MJ & Shtern, F 1995, 'Tumor receptor imaging: Proceedings of the National Cancer Institute Workshop, review of current work, and prospective for further investigations', Clinical Cancer Research, vol. 1, no. 8, pp. 921-932.
Katzenellenbogen, J. A. ; Coleman, R. E. ; Hawkins, R. A. ; Krohn, Kenneth ; Larson, S. M. ; Mendelsohn, J. ; Owborne, C. K. ; Piwnica-Worms, D. ; Reba, R. C. ; Siegel, B. A. ; Welch, M. J. ; Shtern, F. / Tumor receptor imaging : Proceedings of the National Cancer Institute Workshop, review of current work, and prospective for further investigations. In: Clinical Cancer Research. 1995 ; Vol. 1, No. 8. pp. 921-932.
@article{f9e6fefbde7247fc82d61f4631dad142,
title = "Tumor receptor imaging: Proceedings of the National Cancer Institute Workshop, review of current work, and prospective for further investigations",
abstract = "In February 1994, the National Cancer Institute held a workshop to evaluate the current and future role of emission tomographic imaging methods, positron emission tomography and single-photon emission computed tomography, in improving the accuracy of cancer diagnosis and the effectiveness of treatment and in elucidating basic aspects of human cancer biology. Reviews covered many of the receptor and transport systems for hormones and growth factors, as well as metabolic changes important in human cancer, and topical presentations reviewed the current status of receptor-based imaging in the most well-characterized systems: somatostatin receptor imaging of neuroendocrine tumors, estrogen receptor imaging of breast cancer, and epidermal growth factor receptor and tumor metabolic imaging. A critical analysis was made of the current research and of new directions for the future development and use of receptor-imaging methods in oncology. In each area, recommendations were made for further investigation, where emerging understanding of tumor cell biology and defined molecular targets might be combined with the methods of radiopharmaceutical design and evaluation, to develop new approaches to critical issues in the diagnosis, staging, and treatment of cancer through tumor receptor imaging.",
author = "Katzenellenbogen, {J. A.} and Coleman, {R. E.} and Hawkins, {R. A.} and Kenneth Krohn and Larson, {S. M.} and J. Mendelsohn and Owborne, {C. K.} and D. Piwnica-Worms and Reba, {R. C.} and Siegel, {B. A.} and Welch, {M. J.} and F. Shtern",
year = "1995",
language = "English (US)",
volume = "1",
pages = "921--932",
journal = "Clinical Cancer Research",
issn = "1078-0432",
publisher = "American Association for Cancer Research Inc.",
number = "8",

}

TY - JOUR

T1 - Tumor receptor imaging

T2 - Proceedings of the National Cancer Institute Workshop, review of current work, and prospective for further investigations

AU - Katzenellenbogen, J. A.

AU - Coleman, R. E.

AU - Hawkins, R. A.

AU - Krohn, Kenneth

AU - Larson, S. M.

AU - Mendelsohn, J.

AU - Owborne, C. K.

AU - Piwnica-Worms, D.

AU - Reba, R. C.

AU - Siegel, B. A.

AU - Welch, M. J.

AU - Shtern, F.

PY - 1995

Y1 - 1995

N2 - In February 1994, the National Cancer Institute held a workshop to evaluate the current and future role of emission tomographic imaging methods, positron emission tomography and single-photon emission computed tomography, in improving the accuracy of cancer diagnosis and the effectiveness of treatment and in elucidating basic aspects of human cancer biology. Reviews covered many of the receptor and transport systems for hormones and growth factors, as well as metabolic changes important in human cancer, and topical presentations reviewed the current status of receptor-based imaging in the most well-characterized systems: somatostatin receptor imaging of neuroendocrine tumors, estrogen receptor imaging of breast cancer, and epidermal growth factor receptor and tumor metabolic imaging. A critical analysis was made of the current research and of new directions for the future development and use of receptor-imaging methods in oncology. In each area, recommendations were made for further investigation, where emerging understanding of tumor cell biology and defined molecular targets might be combined with the methods of radiopharmaceutical design and evaluation, to develop new approaches to critical issues in the diagnosis, staging, and treatment of cancer through tumor receptor imaging.

AB - In February 1994, the National Cancer Institute held a workshop to evaluate the current and future role of emission tomographic imaging methods, positron emission tomography and single-photon emission computed tomography, in improving the accuracy of cancer diagnosis and the effectiveness of treatment and in elucidating basic aspects of human cancer biology. Reviews covered many of the receptor and transport systems for hormones and growth factors, as well as metabolic changes important in human cancer, and topical presentations reviewed the current status of receptor-based imaging in the most well-characterized systems: somatostatin receptor imaging of neuroendocrine tumors, estrogen receptor imaging of breast cancer, and epidermal growth factor receptor and tumor metabolic imaging. A critical analysis was made of the current research and of new directions for the future development and use of receptor-imaging methods in oncology. In each area, recommendations were made for further investigation, where emerging understanding of tumor cell biology and defined molecular targets might be combined with the methods of radiopharmaceutical design and evaluation, to develop new approaches to critical issues in the diagnosis, staging, and treatment of cancer through tumor receptor imaging.

UR - http://www.scopus.com/inward/record.url?scp=0029071281&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029071281&partnerID=8YFLogxK

M3 - Article

C2 - 9816063

AN - SCOPUS:0029071281

VL - 1

SP - 921

EP - 932

JO - Clinical Cancer Research

JF - Clinical Cancer Research

SN - 1078-0432

IS - 8

ER -